FDA.reportPublic FDA data

cosibelimab-ipdl 300 MG per 5 ML Injection

RxCUI
2717518
RxNorm name
cosibelimab-ipdl 300 MG per 5 ML Injection
Display name
cosibelimab-ipdl 300 MG per 5 ML Injection
Full name
cosibelimab-ipdl 300 MG per 5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761297Unloxcytcosibelimab-ipdl351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
UNLOXCYTCOSIBELIMABSun Pharmaceutical Industries, Inc.06bdadd5-d2db-406f-a3f8-de47f48a52e32025-12-08Warnings, Adverse reactionsExact identifier
rxcui: 2717518

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
06bdadd5-d2db-406f-a3f8-de47f48a52e3cosibelimab-ipdl 300 MG per 5 ML InjectionSY3These highlights do not include all the information needed to use UNLOXCYT safely and effectively. See full prescribing information for UNLOXCYT. UNLOXCYT (cosibelimab-ipdl) injection, for intravenous use Initial U.S. Approval: 202420251208
06bdadd5-d2db-406f-a3f8-de47f48a52e35 ML cosibelimab-ipdl 60 MG/ML InjectionSCD3These highlights do not include all the information needed to use UNLOXCYT safely and effectively. See full prescribing information for UNLOXCYT. UNLOXCYT (cosibelimab-ipdl) injection, for intravenous use Initial U.S. Approval: 202420251208
06bdadd5-d2db-406f-a3f8-de47f48a52e3cosibelimab-ipdl 300 MG in 5 ML InjectionPSN3These highlights do not include all the information needed to use UNLOXCYT safely and effectively. See full prescribing information for UNLOXCYT. UNLOXCYT (cosibelimab-ipdl) injection, for intravenous use Initial U.S. Approval: 202420251208
06bdadd5-d2db-406f-a3f8-de47f48a52e3cosibelimab-ipdl 60 MG/ML per 5 ML InjectionSY3These highlights do not include all the information needed to use UNLOXCYT safely and effectively. See full prescribing information for UNLOXCYT. UNLOXCYT (cosibelimab-ipdl) injection, for intravenous use Initial U.S. Approval: 202420251208